Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1976 1
1977 1
1978 1
1980 1
1981 1
1985 2
1986 1
1987 2
1988 3
1989 3
1990 4
1991 2
1992 2
1993 4
1994 6
1995 6
1996 4
1997 6
1998 3
1999 6
2000 4
2001 6
2002 3
2003 5
2004 4
2005 6
2006 7
2007 2
2008 4
2009 8
2010 7
2011 11
2012 10
2013 2
2014 6
2015 9
2016 7
2017 6
2018 10
2019 16
2020 9
2021 6
2022 6
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Cardiomyopathy and pregnancy.
Schaufelberger M. Schaufelberger M. Heart. 2019 Oct;105(20):1543-1551. doi: 10.1136/heartjnl-2018-313476. Epub 2019 Jul 15. Heart. 2019. PMID: 31308064 Free PMC article. Review.
The most common cardiomyopathies are hypertrophic and dilated cardiomyopathy. Rare types are arrhythmogenic right ventricular, restrictive, Takotsubo and left ventricular non-compaction cardiomyopathies. ...Previous studies on >700 pregnancies in 500 women with …
The most common cardiomyopathies are hypertrophic and dilated cardiomyopathy. Rare types are arrhythmogenic right ventricular, …
New perspectives on the prevalence of hypertrophic cardiomyopathy.
Semsarian C, Ingles J, Maron MS, Maron BJ. Semsarian C, et al. J Am Coll Cardiol. 2015 Mar 31;65(12):1249-1254. doi: 10.1016/j.jacc.2015.01.019. J Am Coll Cardiol. 2015. PMID: 25814232 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which prevalence in the general population has not been completely resolved. For the past 20 years, most data have supported the occurrence of HCM at about 1 in 500. However, t …
Hypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which prevalence in the general population …
Apical Hypertrophic Cardiomyopathy: The Variant Less Known.
Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, Moon JC, Captur G. Hughes RK, et al. J Am Heart Assoc. 2020 Mar 3;9(5):e015294. doi: 10.1161/JAHA.119.015294. Epub 2020 Feb 28. J Am Heart Assoc. 2020. PMID: 32106746 Free PMC article. Review. No abstract available.
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T. Gallo S, et al. Int J Mol Sci. 2019 May 1;20(9):2164. doi: 10.3390/ijms20092164. Int J Mol Sci. 2019. PMID: 31052420 Free PMC article. Review.
Specific ERK-associated scaffold proteins are implicated in either cardioprotective or detrimental hypertrophic functions. Interestingly, ERK phosphorylated at threonine 188 and activated ERK5 (the big MAPK 1) are associated with pathological forms of hypertrophy. Finally, …
Specific ERK-associated scaffold proteins are implicated in either cardioprotective or detrimental hypertrophic functions. Interestin …
Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B. Sedaghat-Hamedani F, et al. Clin Res Cardiol. 2018 Jan;107(1):30-41. doi: 10.1007/s00392-017-1155-5. Epub 2017 Aug 24. Clin Res Cardiol. 2018. PMID: 28840316 Review.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which goes along with increased risk for sudden cardiac death (SCD). ...The average frequency of mutations in MYBPC3 (20%) and MYH7 (14%) was higher than TNNT2 an …
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which goes along with increas …
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments.
Olivotto I, Udelson JE, Pieroni M, Rapezzi C. Olivotto I, et al. Eur Heart J. 2023 Feb 21;44(8):656-667. doi: 10.1093/eurheartj/ehac764. Eur Heart J. 2023. PMID: 36582184 Review.
The present review addressed existing and developing therapies for genetic causes of HFpEF, including hypertrophic cardiomyopathy, cardiac amyloidosis, and storage diseases, discussing their potential impact on management and their broader implications for our under …
The present review addressed existing and developing therapies for genetic causes of HFpEF, including hypertrophic cardiomyopathy …
Pediatric Cardiomyopathies.
Lee TM, Hsu DT, Kantor P, Towbin JA, Ware SM, Colan SD, Chung WK, Jefferies JL, Rossano JW, Castleberry CD, Addonizio LJ, Lal AK, Lamour JM, Miller EM, Thrush PT, Czachor JD, Razoky H, Hill A, Lipshultz SE. Lee TM, et al. Circ Res. 2017 Sep 15;121(7):855-873. doi: 10.1161/CIRCRESAHA.116.309386. Circ Res. 2017. PMID: 28912187 Free PMC article. Review.
Within 2 years of presentation, normalization of function occurs in 20% of children with dilated cardiomyopathy, and 40% die or undergo transplantation. Infants with hypertrophic cardiomyopathy have a 2-year mortality of 30%, whereas death is rare in o …
Within 2 years of presentation, normalization of function occurs in 20% of children with dilated cardiomyopathy, and 40% die o …
Hypertrophic Obstructive Cardiomyopathy.
Batzner A, Schäfers HJ, Borisov KV, Seggewiß H. Batzner A, et al. Dtsch Arztebl Int. 2019 Jan 25;116(4):47-53. doi: 10.3238/arztebl.2019.0047. Dtsch Arztebl Int. 2019. PMID: 30855006 Free PMC article. Review.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%. ...Septum ablation is associated with low perioperative and peri-interventional mortality but necessitates permanent pacemaker implantation in …
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%. ... …
[Hypertrophic cardiomyopathy].
Batzner A, Seggewiß H. Batzner A, et al. Herz. 2020 May;45(3):233-242. doi: 10.1007/s00059-020-04899-y. Herz. 2020. PMID: 32185419 Review. German.
Hypertrophic cardiomyopathy is the most common genetically determined cardiac disease with a prevalence of 0.2-0.6%. ...
Hypertrophic cardiomyopathy is the most common genetically determined cardiac disease with a prevalence of 0.2-0.6%. ...
212 results